-
Canadian Cancer Clinical Trials Network to further improve equitable access to cancer clinical trials with new funding
Support from the Canadian Partnership Against Cancer will further advance 3CTN’s equity, diversity and inclusion initiatives and fund six new projects across Canada March 5th, 2025, TORONTO – The Canadian Partnership Against Cancer (CPAC) has awarded the Canadian Cancer Clinical Trials Network (3CTN) with $600,000 in additional funding to support further efforts to improve access
-
G.A.P.P. Webinar: Epic Electronic Medical Record (EMR) – Lessons Learned & Effective Strategies to Implementation
When: January 30, 2025, from 1 – 2:30 pm ET. 3CTN is excited to announce the upcoming G.A.P.P. Webinar: Epic Electronic Medical Record (EMR) – Lessons Learned & Effective Strategies to Implementation. The implementation of hospital-wide EMR systems and resulting process integration have been reported as presenting challenges for Network Cancer Centre trial units. This
-
3CTN Annual Meeting & Workshop 2024
Workshop – Implementing Best Practices for Equity, Diversity and Inclusion (EDI) in Clinical Trials Wednesday, November 13, 2024 Workshop Summary: This workshop will support Network sites’ plans to improve patient access and participation to cancer clinical trials. Current examples of practical, effective approaches undertaken to address EDI priorities will be shared. Facilitated discussions that follow will
-
Patient Partner Learning & Education Grants
3CTN is excited to offer grant opportunities for Patient Partners across our Network to help cover the cost of participating in educational courses, meetings or conferences. These grants are intended to promote learning and development to enhance the impact of patient engagement in clinical trials across Canada. Individual requests of up to $1,500 will be
-
Revised EDI Framework and Toolkit in Collaboration with Queering Cancer
The latest edition of our Equity, Diversity, and Inclusion (EDI) Framework and Toolkit is now available. In collaboration with Kim Meeking, Co-Lead for Queering Cancer, we have enriched the toolkit with additional resources and best practices aimed at addressing the unique needs of sexual and gender diverse (SGD) communities. This updated revision includes new resources
-
impACCT Virtual Rounds Fall Session 2024
When: Tuesday, October 22, 2024 12:00 pm -1:00 pm EDT Trial #1: (CCTG) SC.29: A Randomized Phase III Trial Comparing Stereotactic Body Radiotherapy to Conventional Palliative Radiotherapy (SBRT) Versus Conventional Palliative Radiotherapy (CRT) for Participants With Painful Non-Spine Bone Metastases Speaker: Dr. Arjun Sahgal, MD, Chief of Radiation Oncology and the Radiation Treatment Program, Sunnybrook
-
-
-
Patient Partner Learning Annex Informational Session
3CTN is excited to announce that we are holding an informational session on June 26, 2024 (1 – 2 pm EDT) for our recently launched Patient Partner Learning Annex tool.
-
impACCT Virtual Rounds Spring Session 2024
When: Thursday, May 23, 2024 12:00 pm -1:00 pm EDT Featured Trial (CHUQ) BicaBCa: A phase II randomized trial of bicalutamide in patients receiving intravesical BCG for non-muscle invasive bladder cancer (NCT05327647) Speaker: Dr. Paul Toren, MD, Associate Professor, Department of Surgery – Faculty of Medicine, Université Laval Speaker: Dr. Joe Pater, MD, Emeritus Professor,
